文献速递泌尿生殖胸部腹部CT

前列腺癌ADT治疗患者CT身体成分与心脏毒性及生存的关联

Associations between CT-Based Body Composition and Cardiotoxicity and Overall Survival in Patients with Prostate Cancer.
PubMed 文献 · Acad Radiol · 2026-09-12

本研究回顾性纳入530例接受雄激素剥夺治疗的前列腺癌患者,在第三腰椎层面测量CT身体成分参数。结果显示,发生癌症治疗相关心功能不全者的骨骼肌指数显著更低;较低骨骼肌指数与心脏毒性风险增加及总生存期较差相关。CT骨骼肌指数有助于基线风险分层。

要点

  • 对接受ADT的前列腺癌患者,阅片时可留意第三腰椎层面骨骼肌面积并计算骨骼肌指数。
  • 骨骼肌指数较低者发生CTRCD风险升高且总生存较差,报告可提示临床关注。
  • 同一CT扫描即可评估身体成分,无需额外检查,便于基线风险分层。

核心结论

  • CT骨骼肌指数有助于对接受ADT的前列腺癌患者进行心脏毒性和总生存的基线风险分层。
  • 较低骨骼肌指数与CTRCD风险增加及总生存较差显著相关。

研究设计与样本

  • 回顾性研究,纳入530例接受雄激素剥夺治疗的前列腺癌患者。
  • 在第三腰椎层面轴位图像测量皮下脂肪组织、内脏脂肪组织和骨骼肌的面积与密度。
  • 采用Logistic回归分析身体成分与CTRCD的关联,采用Cox回归分析身体成分与总生存的关联。

关键影像表现/征象

  • 发生CTRCD患者骨骼肌指数显著低于未发生CTRCD患者,分别为29.16±3.66 cm2/m2和38.3±3.83 cm2/m2。

诊断标准与关键数值

  • 较低骨骼肌指数与CTRCD风险增加相关,比值比=1.965,95%CI「1.459-3.472」,P=0.005。
  • 较低骨骼肌指数与较差总生存相关,风险比=2.201,95%CI「1.817-2.766」,P=0.008。
  • CTRCD发生于45例患者,中位随访45个月期间198例死亡。

临床应用与阅片要点

  • 可在常规腹部或盆腔CT第三腰椎层面测量骨骼肌面积并计算骨骼肌指数,用于基线风险判断。
  • 骨骼肌指数明显减低时,报告中可提示心脏毒性风险和不良生存风险可能增高。
  • 阅片评估时不需额外影像检查,可利用既往前列腺癌患者已完成的CT图像。

局限性

  • 研究为回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The purpose of this study was to investigate the associations of parameters of computed tomography (CT)-based body composition with cancer treatment-related cardiac dysfunction (CTRCD) and with overall survival (OS) in patients with prostate cancer who received androgen deprivation therapy (ADT).

MATERIALS AND METHODS: Patients with prostate cancer treated with ADT were retrospectively included. Parameters of CT-based body composition, including the area and density of subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and skeletal muscle (SM), were measured on axial images at the third lumbar vertebra. The associations between body composition and CTRCD were assessed by logistic regression analysis. The associations between body composition and OS were assessed using Cox regression analysis.

RESULTS: Among the 530 patients enrolled, 45 developed CTRCD, and 198 died during a median follow-up of 45 months (interquartile range, 23-54 months). Patients with CTRCD had a significantly lower SM index than patients without CTRCD (29.16 ± 3.66 vs. 38.3 ± 3.83 cm2/m2, respectively, P < 0.001). A lower SM index was associated with a significantly increased risk of CTRCD (odds ratio = 1.965, 95% CI: 1.459-3.472, P = 0.005) and a poor OS (hazard ratio = 2.201, 95% CI: 1.817-2.766, P = 0.008).

CONCLUSION: Utilization of the CT-based SM index contributes to the baseline risk stratification of cardiotoxicity and OS in patients with prostate cancer treated with ADT.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Qiu, Shen, Tu, et al. Associations between CT-Based Body Composition and Cardiotoxicity and Overall Survival in Patients with Prostate Cancer. Acad Radiol. 2026. PMID: 42731897. doi:10.1016/j.acra.2026.08.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。